Orforglipron is an investigational oral GLP-1 receptor agonist being studied as a potential future treatment for weight management and type 2 diabetes. It is part of an extensive clinical trial programme exploring its safety and effectiveness for people living with obesity and overweight, with or without type 2 diabetes. Unlike many existing GLP-1 medicines, which are injectable, Orforglipron is being developed as a once-daily tablet. It is not currently approved or available in the UK, but ongoing clinical trials are exploring its effectiveness, safety, and potential role in obesity treatment.
Select your preferred options and see the best price
| Pack | Price (£) | ||
|---|---|---|---|
| - | - | 1 | 0.00 |
It looks like you missed filling in questions from the last consultation.Click Here to submit your response.
Notify me once available
No hidden fees
Secure checkout
UK Regulated online pharmacy
Trusted by over 100,000+ customers
Orforglipron is a new oral weight loss tablet currently being researched as a potential treatment for obesity and type 2 diabetes. It belongs to a group of medicines called GLP-1 receptor agonists, which help regulate appetite and blood sugar levels. At the moment, Orforglipron is still in clinical development and has not yet been licensed for use in the UK.
Orforglipron works by mimicking the effects of the natural hormone GLP-1, which plays a role in reducing hunger, increasing feelings of fullness, slowing digestion, and supporting blood sugar control. These effects may help support weight loss when combined with healthy lifestyle changes. Clinical trials are assessing how well this mechanism supports weight management and metabolic health.
In clinical trials, the most commonly reported side effects were similar to other GLP-1 medicines and mainly affected the digestive system. These included nausea, vomiting, diarrhoea, and constipation. Most side effects were described as mild to moderate, but further research is still underway.
Most GLP-1 treatments used for weight loss require injections, often taken weekly. Orforglipron is being developed as a once-daily tablet, which could make it a potential alternative for people who may prefer an oral medicine over injections. Clinical trials are comparing its effect with existing treatments to better understand its role.
Early clinical trials have shown promising results for Orforglipron. According to a press release from Eli Lilly, over 40 weeks, patients taking orforglipron pills had an average weight loss of 9.4% to 14.7%.
A weight reduction of at least 10% by week 36 occurred in 46 to 75% of participants who received orforglipron, compared with 9% of those who received a placebo.
It is important to note that clinical trial data may not indicate real world performance in UK clinical settings, and further studies are still underway.
Orforglipron is a new oral weight loss tablet currently being researched as a potential treatment for obesity and type 2 diabetes. It belongs to a group of medicines called GLP-1 receptor agonists, which help regulate appetite and blood sugar levels. At the moment, Orforglipron is still in clinical development and has not yet been licensed for use in the UK.
Orforglipron works by mimicking the effects of the natural hormone GLP-1, which plays a role in reducing hunger, increasing feelings of fullness, slowing digestion, and supporting blood sugar control. These effects may help support weight loss when combined with healthy lifestyle changes. Clinical trials are assessing how well this mechanism supports weight management and metabolic health.
In clinical trials, the most commonly reported side effects were similar to other GLP-1 medicines and mainly affected the digestive system. These included nausea, vomiting, diarrhoea, and constipation. Most side effects were described as mild to moderate, but further research is still underway.
Most GLP-1 treatments used for weight loss require injections, often taken weekly. Orforglipron is being developed as a once-daily tablet, which could make it a potential alternative for people who may prefer an oral medicine over injections. Clinical trials are comparing its effect with existing treatments to better understand its role.
Early clinical trials have shown promising results for Orforglipron. According to apress release from Eli Lilly, over 40 weeks, patients taking orforglipron pills had an average weight loss of 9.4% to 14.7%.
A weight reduction of at least 10% by week 36 occurred in 46 to 75% of participants who received orforglipron, compared with 9% of those who received a placebo.
It is important to note that clinical trial data may not indicate real world performance in UK clinical settings, and further studies are still underway.
|
|
|
|
|
*% of people losing more than 5% of body weight.
No. Orforglipron is not currently available for weight loss in the UK. It remains an investigational medicine that is still being evaluated in clinical trials and has not yet been approved by the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). This means clinicians cannot prescribe it in the UK at present, and any product marketed as Orforglipron for weight loss online is not a licensed treatment and should be treated with caution. Even if Orforglipron receives approval in other countries, the UK licence and availability will depend on separate regulatory review and authorisation. Experts anticipate it may become available after MHRA approval and subsequent guidance, potentially in 2026 or later, but there is no confirmed timeline yet.
If approved, Orforglipron may be considered for adults living with obesity or overweight, with or without related health conditions such as type 2 diabetes. Final prescribing guidance will depend on UK approval and clinical recommendations once trial results are fully reviewed.
In clinical studies, Orforglipron has been taken as a once-daily oral tablet. However, dosing schedules may change before approval, and no official UK prescribing information is available yet.
Because Orforglipron is not licensed, it should not be purchased online. Any website claiming to sell it may be offering unsafe or unregulated products. Always wait for MHRA approval and seek advice from a qualified healthcare professional.
There is currently no confirmed release date for Orforglipron in the UK. Approval depends on the completion of clinical trials, safety reviews, and regulatory assessment by the MHRA and relevant health technology appraisals. Updates are expected as research and regulatory submissions progress.
Answer a few questions on your health and your fitness goals.
Our clinicians will review your clinical questionnaire to make sure treatment is right for you.
Once approved, you will access our wealth of experience and resources curated by our team and begin your clinical weight loss journey.
Start your weight loss journey heading in the right direction. Our team are here to help. Whether you’re unsure about which medicine is right for you or need help navigating the world of weight loss drugs, our team are on hand to help you make the right decision. We can put you in touch with one of our experienced weight loss clinicians so you can be sure you’re making the best decision with the most accurate information.
To get in touch, contact our Customer Service team on 0800 978 8956 or email [email protected].
Authored By
HARMINDER ‘HARMY’ KAUR
BSc(hons) Pharmacy
GPhC Number: 2061107
Reviewed By
GURDEV SEHMI
BSc Pharm, MRPharmS, Independent Prescriber, Superintendent Pharmacist, Clinical Lead
GPhC Number: 2050925
My Weight Loss Journey with Pharmacy Planet. My name is Michelle, and for as long as I can remember, my weight has been something I struggled with. It affected my confidence, my health, and my overall well-being. I had tried countless diets, exercise ...
My name is Natalie, and for most of my adult life, I’ve struggled with my weight. I’ve tried everything you can imagine—Weight Watchers, Slimming World, calorie counting, Atkins, and even the Cambridge Diet. Some worked for a short time, but nothing ever .....
My name is Linda, and my weight loss journey has been a long and difficult one. I have struggled for years, trying various methods, from Weight Watchers to calorie counting and even gym memberships. Unfortunately, none of these ever provided ....
My Weight Loss Journey with Wegovy and Pharmacy Planet. Losing weight has never been an easy feat for me. I tried all options I had available which were the usual contenders—personal trainers healthy eating, and even strict calorie counting. After all my best ...
For years, trying to lose weight felt impossible. As a woman over 35 navigating losing weight in perimenopause, I’d tried everything—strict diets, intense workouts, even weight loss massages—but nothing worked. Finding it difficult to lose weight became ....
the items you wish to order
by our qualified prescriber
to your door step
